Risk factors for the development of neuroleptic induced akathisia

European Neuropsychopharmacology

Volumn 7, Issue 1, 1997, Pages 51-55

  Miller, C H ^a   Hummer, M ^a   Oberbauer, H ^b   Kurzthaler, I ^b   Decol, C ^b   Fleischhacker, W W ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

antipsychotics; incidence; neuroleptic induced akathisia; neuroleptics; prevalence; risk factors; side effects

Indexed keywords

FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PERPHENAZINE; PIMOZIDE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; AKATHISIA; ARTICLE; CONTROLLED STUDY; DRUG DOSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; INPATIENTS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA;

EID: 0030940990     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(96)00041-7     Document Type: Article

References (26)

1. Ayd, F.J. (1961) A survey of drug induced extrpyramidal reactions. J. Am. Med. Ass. 175, 1054-1060.
2. Ayd, F.J. (1984) High potency neurolpetics and akathisia. J. Clin. Psychopharmacol. 4, 227-230.
3. Barnes, T.R.E. and Braude, W.M. (1985) Akathisia variants and tardive dyskinesia. Arch. Gen. Psychiatry 42, 874-878.
4. Barnes, T.R.E., Braude, W.M. and Hill, J.L. (1982) Acute akathisia after oral droperidol and metoclopramide preoperative medication. Lancet ii, 48-49.
5. Bersani, G., Grispini, A., Marini, S., Pasini, A., Valducci, M. and Ciani, N. (1986) Neuroleptic induced extrapyramidal side effects: Clinical perspectives with ritanserin, a new selective 5HT2 receptor blocking agent. Curr. Ther. Res. 40, 492-499.
6. Braude, W.M., Barnes, T.R.E. and Gore, S.M. (1983) Clinical characteristics of akathisia: A systematic investigation of acute psychiatric inpatient admission. Brit. J. Psychiatry 143, 139-150.
7. Crane, G.E., Naranjo, E.R. and Chase, T.N. (1971) Motor disorder induced by neuroleptics. Arch. Gen. Psychiatry 24, 179-184.
8. Farde, L., Nordstrom, A.L., Wiesel, F.A., Pauli, S., Halldin, C. and Sedvall, G. (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch. Gen. Psychiatry 49, 538-544.
9. Fleischhacker, W.W. (1991) Propanolol for fluoxetine induced akathisia. Biol. Psychiatry 30, 531-532.
10. Fleischhacker, W.W., Bergman, K.J., Pestreich, L.K., Borenstein, M., Lieberman, J.A. and Kane, J.M. (1989) The Hillside Akathisia Scale, a new rating instrument for neuroleptic induced akathisia. Psychopharmcol. Bull. 25, 222-226.
11. Fleischhacker, W.W., Miller, C.H., Schett, P., Barnas, C. and Ehrmann, H. (1991) The Hillside Akathisia Scale: a reliability comparison of the English and German versions. Psychopharmacology 105, 141-144.
12. Fleischhacker, W.W., Roth, S.D. and Kane, J.M. (1990) The pharmacologic treatment of neuroleptic induced akathisia. J. Clin. Psychopharmacol. 10, 12-21.
13. Haskovec, L. (1904) Weitere Bemerkungen über die Akathisie. Wien Med. Wochenschr. 54, 526-530.
14. Lipinski, J.F., Mallya, G., Zimmermann, P. and Pope, H. (1989) Fluoxetine induced akathisia: clinical and theoretical implications. J. Clin. Psychopharmacol. 50, 339-342.
15. Marsden, C.D. and Jenner, P. (1980) The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol. Med. 10, 55-72.
16. Miller, C.H., Fleischhacker, W.W., Ehrmann, H. and Kane, J.M. (1990) Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. Psychopharmacol. Bull. 26, 373-376.
17. National Institute of Mental Health and Psychopharmacology Survey Center Collaborative Study Group (1964) Phenothiazine treatment in acute schizophrenia. Arch. Gen. Psychiatry 10, 161-246.
18. Raskin, D.E. (1972) Akathisia: a side effect to be remembered. Am. J. Psychiatry 129, 345-347.
19. Rey, M.J., Schulz, P., Costa, C., Dick, P. and Tissot, R. (1989) Guidelines for the dosage of neuroleptics. Chlorpromazine equivalents of orally administered neuroleptics. Int. Clin. Psychopharmacol. 4, 95-104.
20. Sachdev, P. and Kruk, J. (1994) Clinical characteristics and predisposing factors in acute drug induced akathisa. Arch. Gen. Psychiatry 51, 963-974.
21. Schmidt, L.G., Grohmann, R., Helmchen, H., Langscheid-Schmidt, K., Müller-Öhrlinghausen, B., Poser, W., Rüther, E., Scherer, J., Strauss, A. and Wolf, B. (1984) Adverse drug reactions. Acta Psychiatr. Scand. 70, 77-89.
22. van Putten, T. (1975) The many faces of akathisia. Comp. Psychiatry 16, 43-47.
23. van Putten, T., Marder, S.R. and Mintz, J.A. (1990) A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Arch. Gen. Psychiatry 47, 754-758.
24. van Putten, T., May, P.R.A. and Marder, S.R. (1984) Akathisia with haloperidol and thiothixene. Arch. Gen. Psychiatry 41, 1036-1039.
25. van Putten, T., May, P.R.A., Marder, S.R. and Wittmann, L.A. (1981) Subjective response to antipsychotic drugs. Arch. Gen. Psychiatry 38, 187-190.
26. Weiden, P.J., Mann, J.J., Haas, G., Mattson, M. and Frances, A. (1987) Clinical nonrecognition of neuroleptic induced movement disorders: a cautionary study. Am. J. Psychiatry 144, 1148-1153.